Grafapex (denosumab) – Rough Cost Overview
| Region | Typical Cost per 60 mg Injection | Comments |
|--------|-----------------------------------|----------|
| United States | $2,500 – $3,500 (before insurance) | Prices are quoted at the pharmacy’s wholesale acquisition cost. Most patients get it covered under Medicare Part B or private insurance, which usually covers a large portion. |
| Canada | $400 – $600 CAD | Provincial drug plans cover the drug; out‑of‑pocket costs can be minimal if you have private coverage. |
| United Kingdom | £200 – £300 | Listed on the NHS and is typically free to patients. |
| European Union (varies) | €250 – €400 | Prices differ by country, but the European Medicines Agency price list offers a guideline. |
| India | ₹3,000 – ₹5,000 | Lower cost due to generics and local manufacturing; still considered a specialty drug. |
How the Cost Adds Up
- Frequency: Grafapex is given once every 4 weeks for bone metastases or once every 12 weeks for osteoporosis (but for bone‑metastasis patients the 4‑week schedule is standard).
- Annual Expense: Roughly 13 injections × $3,000 ≈ $39,000 per year in the U.S. (before insurance).
- Insurance & Assistance: In most U.S. plans, denosumab is classified as a specialty drug and covered under Medicare Part B or private specialty drug coverage. Many manufacturers offer Patient Assistance Programs (PAPs) that can reduce out‑of‑pocket costs to <$50–$100 per visit.
Where to Get Exact Pricing
1. Check with Your Pharmacy or Pharmacy Benefit Manager (PBM): They can give you the current wholesale price and any applicable discounts.
2. Ask Your Physician or Oncology Team: They often know about local cost‑sharing programs or clinical trial opportunities that might cover the drug.
3. Manufacturer’s Patient Assistance Page: The drug’s manufacturer (Roche) lists eligibility criteria and application instructions on their website.
Bottom Line
Grafapex is a high‑cost biologic, but most patients in the U.S. receive substantial insurance coverage, and many countries list it as a reimbursable drug. If cost is a concern, discuss the following options with your prescriber or pharmacist:
- Insurance coverage & copay assistance
- Manufacturer’s PAP
- Generic alternatives (in countries where approved)
- Clinical trials that include the drug at no cost
If you’re looking for a more specific quote for your location or insurance plan, let me know the country and any insurance details, and I can help narrow it down further.